TROPICAL DISEASES:
Drug Companies Decline to Collaborate
Nigel Williams
A group of leading pharmaceutical companies has shot down a proposal for a $180 million joint project to develop new treatments for the world's most threatening tropical diseases, particularly malaria. A group of public and private organizations put the proposal to the drug companies last month, and earlier confidential discussions were thought to be going well. But industry leaders who met in Switzerland last month decided that there are too many uncertainties and potential commercial conflicts to go ahead.